

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.75175625 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.75175625 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.61396592 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.61396592 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.34085426 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.87464045 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.87464045 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.87464045 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.72874775 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.51652958 |
| 11 | cellular ketone body metabolic process (GO:0046950) | 5.45811153 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.44983508 |
| 13 | lysine catabolic process (GO:0006554) | 5.22355775 |
| 14 | lysine metabolic process (GO:0006553) | 5.22355775 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.14753627 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07672394 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.94439868 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79190716 |
| 19 | cysteine metabolic process (GO:0006534) | 4.78809324 |
| 20 | ketone body metabolic process (GO:1902224) | 4.71768658 |
| 21 | aromatic amino acid family metabolic process (GO:0009072) | 4.70704575 |
| 22 | amino-acid betaine metabolic process (GO:0006577) | 4.66346012 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.64098824 |
| 24 | urea cycle (GO:0000050) | 4.58333423 |
| 25 | urea metabolic process (GO:0019627) | 4.58333423 |
| 26 | regulation of mitochondrial translation (GO:0070129) | 4.57942558 |
| 27 | alpha-amino acid catabolic process (GO:1901606) | 4.56744189 |
| 28 | short-chain fatty acid metabolic process (GO:0046459) | 4.56491268 |
| 29 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.49424259 |
| 30 | ATP synthesis coupled proton transport (GO:0015986) | 4.49424259 |
| 31 | fatty acid beta-oxidation (GO:0006635) | 4.44161431 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 4.44069676 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.35212039 |
| 34 | branched-chain amino acid catabolic process (GO:0009083) | 4.32831263 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 4.30079136 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 4.27796264 |
| 37 | amine catabolic process (GO:0009310) | 4.26605771 |
| 38 | cellular biogenic amine catabolic process (GO:0042402) | 4.26605771 |
| 39 | cellular amino acid catabolic process (GO:0009063) | 4.26003879 |
| 40 | aspartate family amino acid catabolic process (GO:0009068) | 4.24725093 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.23912073 |
| 42 | bile acid metabolic process (GO:0008206) | 4.22129177 |
| 43 | fatty acid oxidation (GO:0019395) | 4.20388457 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 4.18769755 |
| 45 | fatty acid catabolic process (GO:0009062) | 4.16927656 |
| 46 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.16876668 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.16414046 |
| 48 | acetyl-CoA metabolic process (GO:0006084) | 4.15904159 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.14696083 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.14134417 |
| 51 | cellular glucuronidation (GO:0052695) | 4.13324653 |
| 52 | lipid oxidation (GO:0034440) | 4.11412538 |
| 53 | 2-oxoglutarate metabolic process (GO:0006103) | 4.10818670 |
| 54 | monocarboxylic acid catabolic process (GO:0072329) | 4.06393252 |
| 55 | aldehyde catabolic process (GO:0046185) | 4.05144124 |
| 56 | branched-chain amino acid metabolic process (GO:0009081) | 4.03385334 |
| 57 | organic acid catabolic process (GO:0016054) | 4.03170457 |
| 58 | carboxylic acid catabolic process (GO:0046395) | 4.03170457 |
| 59 | oxidative phosphorylation (GO:0006119) | 4.00018675 |
| 60 | respiratory electron transport chain (GO:0022904) | 3.97439200 |
| 61 | drug transmembrane transport (GO:0006855) | 3.96824586 |
| 62 | chaperone-mediated protein transport (GO:0072321) | 3.95786545 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.95207928 |
| 64 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.92023832 |
| 65 | carnitine metabolic process (GO:0009437) | 3.91275957 |
| 66 | ethanol oxidation (GO:0006069) | 3.90980140 |
| 67 | protein complex biogenesis (GO:0070271) | 3.90400622 |
| 68 | electron transport chain (GO:0022900) | 3.89486028 |
| 69 | negative regulation of fibrinolysis (GO:0051918) | 3.88994355 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 3.88740328 |
| 71 | glutamate metabolic process (GO:0006536) | 3.88675641 |
| 72 | glucuronate metabolic process (GO:0019585) | 3.88137220 |
| 73 | uronic acid metabolic process (GO:0006063) | 3.88137220 |
| 74 | complement activation, alternative pathway (GO:0006957) | 3.84437269 |
| 75 | acylglycerol homeostasis (GO:0055090) | 3.83612089 |
| 76 | triglyceride homeostasis (GO:0070328) | 3.83612089 |
| 77 | valine metabolic process (GO:0006573) | 3.83424458 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.80117223 |
| 79 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.79987195 |
| 80 | NADH dehydrogenase complex assembly (GO:0010257) | 3.79987195 |
| 81 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.79987195 |
| 82 | NAD biosynthetic process (GO:0009435) | 3.79597591 |
| 83 | regulation of protein activation cascade (GO:2000257) | 3.79103832 |
| 84 | drug catabolic process (GO:0042737) | 3.78784541 |
| 85 | glycine metabolic process (GO:0006544) | 3.76117910 |
| 86 | protein carboxylation (GO:0018214) | 3.75908614 |
| 87 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.75908614 |
| 88 | urate metabolic process (GO:0046415) | 3.74228827 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73080103 |
| 90 | respiratory chain complex IV assembly (GO:0008535) | 3.72251927 |
| 91 | arginine metabolic process (GO:0006525) | 3.72070835 |
| 92 | tricarboxylic acid cycle (GO:0006099) | 3.68234186 |
| 93 | cullin deneddylation (GO:0010388) | 3.66613517 |
| 94 | regulation of cholesterol esterification (GO:0010872) | 3.66598974 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.64312608 |
| 96 | benzene-containing compound metabolic process (GO:0042537) | 3.62235852 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.59699462 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 3.59044769 |
| 99 | protein-lipid complex remodeling (GO:0034368) | 3.57861415 |
| 100 | macromolecular complex remodeling (GO:0034367) | 3.57861415 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 3.57861415 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57260016 |
| 103 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57260016 |
| 104 | reverse cholesterol transport (GO:0043691) | 3.55466829 |
| 105 | bile acid and bile salt transport (GO:0015721) | 3.55331643 |
| 106 | ubiquinone biosynthetic process (GO:0006744) | 3.53756375 |
| 107 | regulation of complement activation (GO:0030449) | 3.50700819 |
| 108 | biotin metabolic process (GO:0006768) | 3.49302647 |
| 109 | protein deneddylation (GO:0000338) | 3.47220192 |
| 110 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.47094930 |
| 111 | small molecule catabolic process (GO:0044282) | 3.47001646 |
| 112 | NAD metabolic process (GO:0019674) | 3.45012988 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.44894650 |
| 114 | cofactor catabolic process (GO:0051187) | 3.42251750 |
| 115 | phospholipid efflux (GO:0033700) | 3.41199855 |
| 116 | exogenous drug catabolic process (GO:0042738) | 3.40906230 |
| 117 | fructose metabolic process (GO:0006000) | 3.39404480 |
| 118 | succinate metabolic process (GO:0006105) | 3.34659955 |
| 119 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.32009519 |
| 120 | negative regulation of lipase activity (GO:0060192) | 3.31176730 |
| 121 | ubiquinone metabolic process (GO:0006743) | 3.31130676 |
| 122 | cytochrome complex assembly (GO:0017004) | 3.26418366 |
| 123 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.26165971 |
| 124 | proteasome assembly (GO:0043248) | 3.22132633 |
| 125 | protein targeting to mitochondrion (GO:0006626) | 3.20080375 |
| 126 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.16045844 |
| 127 | mitochondrial RNA metabolic process (GO:0000959) | 3.12575335 |
| 128 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.09480161 |
| 129 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.09480161 |
| 130 | maturation of 5.8S rRNA (GO:0000460) | 3.08180110 |
| 131 | DNA double-strand break processing (GO:0000729) | 3.03920085 |
| 132 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.00135116 |
| 133 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.95829686 |
| 134 | protein localization to mitochondrion (GO:0070585) | 2.93280704 |
| 135 | establishment of protein localization to mitochondrion (GO:0072655) | 2.93271105 |
| 136 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.92990607 |
| 137 | termination of RNA polymerase III transcription (GO:0006386) | 2.92990607 |
| 138 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.92692625 |
| 139 | amino acid salvage (GO:0043102) | 2.91908702 |
| 140 | L-methionine salvage (GO:0071267) | 2.91908702 |
| 141 | L-methionine biosynthetic process (GO:0071265) | 2.91908702 |
| 142 | quinone biosynthetic process (GO:1901663) | 2.91528557 |
| 143 | ribosome assembly (GO:0042255) | 2.90979601 |
| 144 | negative regulation of ligase activity (GO:0051352) | 2.90956260 |
| 145 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.90956260 |
| 146 | rRNA modification (GO:0000154) | 2.88833318 |
| 147 | aerobic respiration (GO:0009060) | 2.87641787 |
| 148 | ATP biosynthetic process (GO:0006754) | 2.87224635 |
| 149 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.86690611 |
| 150 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.85017710 |
| 151 | pseudouridine synthesis (GO:0001522) | 2.81603638 |
| 152 | cellular component biogenesis (GO:0044085) | 2.81231574 |
| 153 | spliceosomal snRNP assembly (GO:0000387) | 2.80372598 |
| 154 | ribosome biogenesis (GO:0042254) | 2.77366802 |
| 155 | IMP biosynthetic process (GO:0006188) | 2.77302299 |
| 156 | protein-cofactor linkage (GO:0018065) | 2.77142219 |
| 157 | inner mitochondrial membrane organization (GO:0007007) | 2.76703808 |
| 158 | hydrogen ion transmembrane transport (GO:1902600) | 2.75703015 |
| 159 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.75596162 |
| 160 | iron-sulfur cluster assembly (GO:0016226) | 2.75170350 |
| 161 | metallo-sulfur cluster assembly (GO:0031163) | 2.75170350 |
| 162 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.75127474 |
| 163 | amino acid activation (GO:0043038) | 2.72372479 |
| 164 | tRNA aminoacylation (GO:0043039) | 2.72372479 |
| 165 | establishment of integrated proviral latency (GO:0075713) | 2.72326529 |
| 166 | tRNA aminoacylation for protein translation (GO:0006418) | 2.72256701 |
| 167 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.71940708 |
| 168 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.71940708 |
| 169 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.71822844 |
| 170 | DNA damage response, detection of DNA damage (GO:0042769) | 2.68036958 |
| 171 | purine nucleobase biosynthetic process (GO:0009113) | 2.67863965 |
| 172 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.67571151 |
| 173 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.67380041 |
| 174 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.66824766 |
| 175 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.65936882 |
| 176 | maturation of SSU-rRNA (GO:0030490) | 2.65340060 |
| 177 | peptidyl-histidine modification (GO:0018202) | 2.63930446 |
| 178 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.63451401 |
| 179 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.63451401 |
| 180 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.63451401 |
| 181 | chromatin remodeling at centromere (GO:0031055) | 2.62495463 |
| 182 | cellular respiration (GO:0045333) | 2.61701588 |
| 183 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61444561 |
| 184 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61444561 |
| 185 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.61181332 |
| 186 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.61181332 |
| 187 | mitochondrial transport (GO:0006839) | 2.60789130 |
| 188 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.60227905 |
| 189 | DNA strand elongation (GO:0022616) | 2.60105626 |
| 190 | regulation of coenzyme metabolic process (GO:0051196) | 2.58330008 |
| 191 | regulation of cofactor metabolic process (GO:0051193) | 2.58330008 |
| 192 | nucleobase biosynthetic process (GO:0046112) | 2.57404622 |
| 193 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.56883317 |
| 194 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.56883317 |
| 195 | positive regulation of ligase activity (GO:0051351) | 2.56619405 |
| 196 | tRNA metabolic process (GO:0006399) | 2.56186612 |
| 197 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.55378457 |
| 198 | transcription from mitochondrial promoter (GO:0006390) | 2.54378028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.87225170 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.80835248 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.05191655 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.80803013 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.79726113 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24574606 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80439194 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.52370647 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.28583901 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.95034302 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.81619632 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.55678958 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.41370851 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.33600229 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.31876789 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.29769904 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.07883662 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.00336769 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.70452604 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.67730568 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.66667877 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.56581283 |
| 23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.35483512 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35072690 |
| 25 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29917422 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.28573853 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.25135651 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21508519 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.20017734 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.18854684 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.15644700 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.15416434 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.10070277 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.06675884 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06082887 |
| 36 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.02504083 |
| 37 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.96333241 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.94431617 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.90514589 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.89893163 |
| 41 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89448639 |
| 42 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.87315208 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.85255286 |
| 44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77183690 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.76623109 |
| 46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74538140 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.73623245 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73009111 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65759151 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.59572240 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.59025532 |
| 52 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52011426 |
| 53 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48369209 |
| 54 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46941156 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.46617447 |
| 56 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.43157478 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41443524 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37968058 |
| 59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.37177390 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35122495 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34175263 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33372561 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32035385 |
| 64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26934506 |
| 65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25736737 |
| 66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25699084 |
| 67 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.25248872 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20110347 |
| 69 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18795627 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18255107 |
| 71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.17207338 |
| 72 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11873032 |
| 73 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10607283 |
| 74 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08862332 |
| 75 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08365849 |
| 76 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06684459 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05329095 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.01444489 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01118188 |
| 80 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.00529489 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00414788 |
| 82 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00404469 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99043314 |
| 84 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98757762 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98416053 |
| 86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97865193 |
| 87 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97457053 |
| 88 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96947383 |
| 89 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96703273 |
| 90 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96522570 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95626261 |
| 92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94496786 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93936637 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92483416 |
| 95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91272408 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89197089 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87933703 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87794659 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87692769 |
| 100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.86287240 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85960800 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85871824 |
| 103 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84746987 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84321887 |
| 105 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84230083 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83300247 |
| 107 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83235667 |
| 108 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.81604699 |
| 109 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.81397065 |
| 110 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.80324111 |
| 111 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.79879901 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79804580 |
| 113 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.79478403 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79110052 |
| 115 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.78498029 |
| 116 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.77392690 |
| 117 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.76026093 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75836560 |
| 119 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.75374712 |
| 120 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.74763356 |
| 121 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74329591 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74271059 |
| 123 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74219252 |
| 124 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.73940119 |
| 125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73808388 |
| 126 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.73405942 |
| 127 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.73047113 |
| 128 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.72709756 |
| 129 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72274635 |
| 130 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.72100271 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72076647 |
| 132 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.71796882 |
| 133 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71674943 |
| 134 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.71291569 |
| 135 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.70955708 |
| 136 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.70603548 |
| 137 | CBP_21632823_ChIP-Seq_H3396_Human | 0.70112510 |
| 138 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69366549 |
| 139 | P300_19829295_ChIP-Seq_ESCs_Human | 0.68756430 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.68158013 |
| 141 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.67710675 |
| 142 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.66142539 |
| 143 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.64452516 |
| 144 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.61952622 |
| 145 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.61952622 |
| 146 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.61033928 |
| 147 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60304296 |
| 148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60248444 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60248444 |
| 150 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.59782682 |
| 151 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.58764442 |
| 152 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.58078426 |
| 153 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.58032223 |
| 154 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57109107 |
| 155 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.56860817 |
| 156 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.56720466 |
| 157 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.56704527 |
| 158 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.56615493 |
| 159 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.56395616 |
| 160 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55848456 |
| 161 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.55628937 |
| 162 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.55544409 |
| 163 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.55383599 |
| 164 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54573778 |
| 165 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.54532814 |
| 166 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54297104 |
| 167 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.53469810 |
| 168 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.53266736 |
| 169 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.53135537 |
| 170 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.53028330 |
| 171 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.52309224 |
| 172 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.52231311 |
| 173 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.52219058 |
| 174 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.51995386 |
| 175 | NCOR_22424771_ChIP-Seq_293T_Human | 0.51347982 |
| 176 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.51278350 |
| 177 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.51149031 |
| 178 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.51143482 |
| 179 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.50650816 |
| 180 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.50425740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.25170540 |
| 2 | MP0005360_urolithiasis | 6.87566284 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.77087967 |
| 4 | MP0005365_abnormal_bile_salt | 5.25682115 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.46855481 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.18106403 |
| 7 | MP0005332_abnormal_amino_acid | 3.24444068 |
| 8 | MP0008058_abnormal_DNA_repair | 3.15106067 |
| 9 | MP0003195_calcinosis | 3.14749553 |
| 10 | MP0003252_abnormal_bile_duct | 3.04254879 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.90154615 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.56620765 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.53607834 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.36392934 |
| 15 | MP0005451_abnormal_body_composition | 2.33960435 |
| 16 | MP0003693_abnormal_embryo_hatching | 2.31822554 |
| 17 | MP0003880_abnormal_central_pattern | 2.29984440 |
| 18 | MP0005083_abnormal_biliary_tract | 2.22330989 |
| 19 | MP0009840_abnormal_foam_cell | 2.18069666 |
| 20 | MP0001764_abnormal_homeostasis | 2.12580030 |
| 21 | MP0009046_muscle_twitch | 2.08401100 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.03469596 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.02286523 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 1.98694339 |
| 25 | MP0003111_abnormal_nucleus_morphology | 1.96957707 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.95799973 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.81512704 |
| 28 | MP0003646_muscle_fatigue | 1.79043954 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.78313633 |
| 30 | MP0009697_abnormal_copulation | 1.76687707 |
| 31 | MP0005670_abnormal_white_adipose | 1.73340317 |
| 32 | MP0000609_abnormal_liver_physiology | 1.72577240 |
| 33 | MP0003186_abnormal_redox_activity | 1.70719297 |
| 34 | MP0003868_abnormal_feces_composition | 1.67052303 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.66803613 |
| 36 | MP0001984_abnormal_olfaction | 1.60585759 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.60187870 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.56768064 |
| 39 | MP0004043_abnormal_pH_regulation | 1.54546122 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.52897671 |
| 41 | MP0003718_maternal_effect | 1.52207809 |
| 42 | MP0004233_abnormal_muscle_weight | 1.51860607 |
| 43 | MP0004957_abnormal_blastocyst_morpholog | 1.51556170 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.51504542 |
| 45 | MP0004270_analgesia | 1.47854883 |
| 46 | MP0003077_abnormal_cell_cycle | 1.46501379 |
| 47 | MP0002272_abnormal_nervous_system | 1.44038923 |
| 48 | MP0003786_premature_aging | 1.43737615 |
| 49 | MP0008932_abnormal_embryonic_tissue | 1.38485988 |
| 50 | MP0006292_abnormal_olfactory_placode | 1.37508782 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.37094143 |
| 52 | MP0004130_abnormal_muscle_cell | 1.36896381 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.33960778 |
| 54 | MP0008789_abnormal_olfactory_epithelium | 1.33131517 |
| 55 | MP0004859_abnormal_synaptic_plasticity | 1.32269117 |
| 56 | MP0009745_abnormal_behavioral_response | 1.31652075 |
| 57 | MP0002064_seizures | 1.30344730 |
| 58 | MP0001661_extended_life_span | 1.28164272 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.27757915 |
| 60 | MP0005535_abnormal_body_temperature | 1.25274787 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.23493403 |
| 62 | MP0005330_cardiomyopathy | 1.23008237 |
| 63 | MP0008877_abnormal_DNA_methylation | 1.22776025 |
| 64 | MP0002102_abnormal_ear_morphology | 1.17675745 |
| 65 | MP0003122_maternal_imprinting | 1.16744472 |
| 66 | MP0002090_abnormal_vision | 1.16654231 |
| 67 | MP0005647_abnormal_sex_gland | 1.16466209 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.16369596 |
| 69 | MP0005499_abnormal_olfactory_system | 1.15169271 |
| 70 | MP0005394_taste/olfaction_phenotype | 1.15169271 |
| 71 | MP0002736_abnormal_nociception_after | 1.15035295 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.14724540 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.13867043 |
| 74 | MP0001968_abnormal_touch/_nociception | 1.13630205 |
| 75 | MP0002160_abnormal_reproductive_system | 1.11984033 |
| 76 | MP0000358_abnormal_cell_content/ | 1.11906789 |
| 77 | MP0003011_delayed_dark_adaptation | 1.10913248 |
| 78 | MP0003635_abnormal_synaptic_transmissio | 1.10689931 |
| 79 | MP0002938_white_spotting | 1.10232060 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 1.08657083 |
| 81 | MP0002971_abnormal_brown_adipose | 1.07774302 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 1.07479718 |
| 83 | MP0005253_abnormal_eye_physiology | 1.06715564 |
| 84 | MP0002822_catalepsy | 1.05090390 |
| 85 | MP0004147_increased_porphyrin_level | 1.01945115 |
| 86 | MP0004036_abnormal_muscle_relaxation | 1.00823514 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.96057545 |
| 88 | MP0005266_abnormal_metabolism | 0.95995280 |
| 89 | MP0002106_abnormal_muscle_physiology | 0.95984091 |
| 90 | MP0008007_abnormal_cellular_replicative | 0.95774128 |
| 91 | MP0002572_abnormal_emotion/affect_behav | 0.94165728 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.93098619 |
| 93 | MP0005423_abnormal_somatic_nervous | 0.92588435 |
| 94 | MP0000750_abnormal_muscle_regeneration | 0.89618528 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.89276056 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.89182516 |
| 97 | MP0000751_myopathy | 0.89012432 |
| 98 | MP0002734_abnormal_mechanical_nocicepti | 0.87286598 |
| 99 | MP0005334_abnormal_fat_pad | 0.87240036 |
| 100 | MP0008260_abnormal_autophagy | 0.86264772 |
| 101 | MP0001486_abnormal_startle_reflex | 0.86178413 |
| 102 | MP0000749_muscle_degeneration | 0.85908637 |
| 103 | MP0009764_decreased_sensitivity_to | 0.85739991 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.85093088 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.83978557 |
| 106 | MP0001756_abnormal_urination | 0.83842835 |
| 107 | MP0003121_genomic_imprinting | 0.83342634 |
| 108 | MP0004811_abnormal_neuron_physiology | 0.81513695 |
| 109 | MP0000598_abnormal_liver_morphology | 0.79380876 |
| 110 | MP0004924_abnormal_behavior | 0.79377508 |
| 111 | MP0005386_behavior/neurological_phenoty | 0.79377508 |
| 112 | MP0000759_abnormal_skeletal_muscle | 0.78639122 |
| 113 | MP0002063_abnormal_learning/memory/cond | 0.77594057 |
| 114 | MP0003137_abnormal_impulse_conducting | 0.76941527 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.76932198 |
| 116 | MP0009763_increased_sensitivity_to | 0.76787045 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.76064870 |
| 118 | MP0003690_abnormal_glial_cell | 0.75508605 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.75452374 |
| 120 | MP0002229_neurodegeneration | 0.74439987 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74139069 |
| 122 | MP0008469_abnormal_protein_level | 0.72990561 |
| 123 | MP0004133_heterotaxia | 0.71856701 |
| 124 | MP0002733_abnormal_thermal_nociception | 0.71680365 |
| 125 | MP0002210_abnormal_sex_determination | 0.69992337 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.69751834 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.69347726 |
| 128 | MP0001929_abnormal_gametogenesis | 0.69054424 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.69004973 |
| 130 | MP0004084_abnormal_cardiac_muscle | 0.68330954 |
| 131 | MP0001529_abnormal_vocalization | 0.67858324 |
| 132 | MP0002269_muscular_atrophy | 0.67812658 |
| 133 | MP0004142_abnormal_muscle_tone | 0.67520973 |
| 134 | MP0005620_abnormal_muscle_contractility | 0.65562538 |
| 135 | MP0005646_abnormal_pituitary_gland | 0.65053910 |
| 136 | MP0008872_abnormal_physiological_respon | 0.63639705 |
| 137 | MP0000747_muscle_weakness | 0.63217687 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.61536475 |
| 139 | MP0001765_abnormal_ion_homeostasis | 0.61241763 |
| 140 | MP0005408_hypopigmentation | 0.61226115 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.58371718 |
| 142 | MP0003953_abnormal_hormone_level | 0.57529738 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57178746 |
| 144 | MP0005448_abnormal_energy_balance | 0.57056834 |
| 145 | MP0008874_decreased_physiological_sensi | 0.54299348 |
| 146 | MP0003959_abnormal_lean_body | 0.54241655 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.53716688 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.53716688 |
| 149 | MP0000604_amyloidosis | 0.53596911 |
| 150 | MP0004085_abnormal_heartbeat | 0.51296991 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.48320449 |
| 152 | MP0008775_abnormal_heart_ventricle | 0.47871683 |
| 153 | MP0004145_abnormal_muscle_electrophysio | 0.46983224 |
| 154 | MP0009115_abnormal_fat_cell | 0.46047224 |
| 155 | MP0004087_abnormal_muscle_fiber | 0.43992802 |
| 156 | MP0005452_abnormal_adipose_tissue | 0.43877358 |
| 157 | MP0000538_abnormal_urinary_bladder | 0.42519662 |
| 158 | MP0001905_abnormal_dopamine_level | 0.42240260 |
| 159 | MP0006138_congestive_heart_failure | 0.39778142 |
| 160 | MP0002254_reproductive_system_inflammat | 0.37817134 |
| 161 | MP0005058_abnormal_lysosome_morphology | 0.37792968 |
| 162 | MP0000639_abnormal_adrenal_gland | 0.37129507 |
| 163 | MP0005595_abnormal_vascular_smooth | 0.37033909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.75102370 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.04135144 |
| 3 | Hyperammonemia (HP:0001987) | 4.61916315 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 4.54264952 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.47116568 |
| 6 | Hyperglycinuria (HP:0003108) | 4.39949085 |
| 7 | Hyperglycinemia (HP:0002154) | 4.38653300 |
| 8 | Ketosis (HP:0001946) | 4.35437001 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.31472828 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.30792621 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.30032274 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.30032274 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.28010563 |
| 14 | Xanthomatosis (HP:0000991) | 4.27457854 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.27358301 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.25515349 |
| 17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.13680383 |
| 18 | Dicarboxylic aciduria (HP:0003215) | 4.13680383 |
| 19 | Cerebral edema (HP:0002181) | 4.00448315 |
| 20 | Hepatic necrosis (HP:0002605) | 3.75536168 |
| 21 | Generalized aminoaciduria (HP:0002909) | 3.69062136 |
| 22 | Ketoacidosis (HP:0001993) | 3.64873073 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.54731551 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 3.49740491 |
| 25 | Acute encephalopathy (HP:0006846) | 3.49360914 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.45970901 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.41065095 |
| 28 | Hypolipoproteinemia (HP:0010981) | 3.39874506 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38990678 |
| 30 | Lethargy (HP:0001254) | 3.38682479 |
| 31 | Epidermoid cyst (HP:0200040) | 3.38297563 |
| 32 | Abnormality of serum amino acid levels (HP:0003112) | 3.31479465 |
| 33 | Joint hemorrhage (HP:0005261) | 3.28215084 |
| 34 | Metabolic acidosis (HP:0001942) | 3.26307291 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.25208886 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.21550581 |
| 37 | Complement deficiency (HP:0004431) | 3.18900464 |
| 38 | Proximal tubulopathy (HP:0000114) | 3.18154996 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.09998249 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.07426563 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 3.06913332 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.04809011 |
| 43 | Renal cortical cysts (HP:0000803) | 3.03645030 |
| 44 | Hepatocellular necrosis (HP:0001404) | 3.03254771 |
| 45 | Exercise intolerance (HP:0003546) | 3.00437543 |
| 46 | Abnormality of the labia minora (HP:0012880) | 2.96569195 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.93659599 |
| 48 | Cerebral hypomyelination (HP:0006808) | 2.89688702 |
| 49 | Glycosuria (HP:0003076) | 2.86328207 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.86328207 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.85076846 |
| 52 | Methylmalonic aciduria (HP:0012120) | 2.83642589 |
| 53 | Increased CSF lactate (HP:0002490) | 2.82283875 |
| 54 | Microvesicular hepatic steatosis (HP:0001414) | 2.80155449 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.78503478 |
| 56 | Abnormality of glycolysis (HP:0004366) | 2.78503478 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.76751602 |
| 58 | Fat malabsorption (HP:0002630) | 2.76670433 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.75341633 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74692025 |
| 61 | Gout (HP:0001997) | 2.73895085 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.73662237 |
| 63 | Vomiting (HP:0002013) | 2.72112530 |
| 64 | Hyperbilirubinemia (HP:0002904) | 2.71031321 |
| 65 | Lactic acidosis (HP:0003128) | 2.68459711 |
| 66 | Myoglobinuria (HP:0002913) | 2.66823764 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.65752210 |
| 68 | Exercise-induced muscle cramps (HP:0003710) | 2.65443131 |
| 69 | Renal Fanconi syndrome (HP:0001994) | 2.56843490 |
| 70 | Myokymia (HP:0002411) | 2.55301347 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.54230033 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43720763 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.43319354 |
| 74 | Multiple enchondromatosis (HP:0005701) | 2.43115217 |
| 75 | Nausea (HP:0002018) | 2.40013491 |
| 76 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39675081 |
| 77 | Leukodystrophy (HP:0002415) | 2.36854502 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36353825 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.36090761 |
| 80 | CNS hypomyelination (HP:0003429) | 2.36081596 |
| 81 | Optic disc pallor (HP:0000543) | 2.34341331 |
| 82 | Enlarged kidneys (HP:0000105) | 2.34127586 |
| 83 | Hyperventilation (HP:0002883) | 2.33423349 |
| 84 | Increased serum lactate (HP:0002151) | 2.30931379 |
| 85 | Methylmalonic acidemia (HP:0002912) | 2.30728905 |
| 86 | Hypercholesterolemia (HP:0003124) | 2.29593964 |
| 87 | Rimmed vacuoles (HP:0003805) | 2.25581722 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.23596582 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.23335712 |
| 90 | Vascular calcification (HP:0004934) | 2.21685694 |
| 91 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.19828391 |
| 92 | Exercise-induced myalgia (HP:0003738) | 2.19062231 |
| 93 | Opisthotonus (HP:0002179) | 2.17030580 |
| 94 | Abnormality of complement system (HP:0005339) | 2.16276978 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.15028144 |
| 96 | Cholecystitis (HP:0001082) | 2.15028144 |
| 97 | Cholelithiasis (HP:0001081) | 2.14828447 |
| 98 | Spontaneous abortion (HP:0005268) | 2.14462213 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 2.13489787 |
| 100 | Increased purine levels (HP:0004368) | 2.12517607 |
| 101 | Hyperuricemia (HP:0002149) | 2.12517607 |
| 102 | Emotional lability (HP:0000712) | 2.09964295 |
| 103 | Progressive muscle weakness (HP:0003323) | 2.09837038 |
| 104 | Steatorrhea (HP:0002570) | 2.08329698 |
| 105 | 3-Methylglutaconic aciduria (HP:0003535) | 2.08196187 |
| 106 | Rhabdomyolysis (HP:0003201) | 2.07403309 |
| 107 | Type I transferrin isoform profile (HP:0003642) | 2.06565574 |
| 108 | Alkalosis (HP:0001948) | 2.05605811 |
| 109 | Muscle fiber inclusion bodies (HP:0100299) | 2.03091415 |
| 110 | CNS demyelination (HP:0007305) | 2.03027450 |
| 111 | Respiratory difficulties (HP:0002880) | 2.00500083 |
| 112 | Respiratory failure (HP:0002878) | 2.00404416 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99900542 |
| 114 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.96855237 |
| 115 | Skin nodule (HP:0200036) | 1.96748043 |
| 116 | Irritability (HP:0000737) | 1.95563171 |
| 117 | Hypokinesia (HP:0002375) | 1.95145453 |
| 118 | Nemaline bodies (HP:0003798) | 1.94926654 |
| 119 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89973405 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 1.89973405 |
| 121 | Hyperalaninemia (HP:0003348) | 1.89973405 |
| 122 | Abnormality of vitamin metabolism (HP:0100508) | 1.89482659 |
| 123 | Neoplasm of the adrenal gland (HP:0100631) | 1.89427882 |
| 124 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.89230102 |
| 125 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.85293070 |
| 126 | Gliosis (HP:0002171) | 1.81914147 |
| 127 | Abnormal protein glycosylation (HP:0012346) | 1.79348313 |
| 128 | Abnormal glycosylation (HP:0012345) | 1.79348313 |
| 129 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.79348313 |
| 130 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79348313 |
| 131 | Palpitations (HP:0001962) | 1.79226927 |
| 132 | Medial flaring of the eyebrow (HP:0010747) | 1.77926245 |
| 133 | Hypoplastic pelvis (HP:0008839) | 1.77786683 |
| 134 | Sudden death (HP:0001699) | 1.77686978 |
| 135 | X-linked dominant inheritance (HP:0001423) | 1.76746750 |
| 136 | Abnormal number of erythroid precursors (HP:0012131) | 1.75412490 |
| 137 | Double outlet right ventricle (HP:0001719) | 1.73521440 |
| 138 | Congenital malformation of the right heart (HP:0011723) | 1.73521440 |
| 139 | Abnormality of placental membranes (HP:0011409) | 1.72477783 |
| 140 | Amniotic constriction ring (HP:0009775) | 1.72477783 |
| 141 | Bundle branch block (HP:0011710) | 1.71871077 |
| 142 | Chromsome breakage (HP:0040012) | 1.70361155 |
| 143 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.65608275 |
| 144 | Poor eye contact (HP:0000817) | 1.64866143 |
| 145 | Exertional dyspnea (HP:0002875) | 1.61759567 |
| 146 | Gait imbalance (HP:0002141) | 1.60883979 |
| 147 | Delusions (HP:0000746) | 1.60579463 |
| 148 | Congenital primary aphakia (HP:0007707) | 1.59776650 |
| 149 | Colon cancer (HP:0003003) | 1.59621694 |
| 150 | Poor suck (HP:0002033) | 1.59538497 |
| 151 | Progressive microcephaly (HP:0000253) | 1.59241501 |
| 152 | EMG: myopathic abnormalities (HP:0003458) | 1.57672469 |
| 153 | Birth length less than 3rd percentile (HP:0003561) | 1.57010356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.83393607 |
| 2 | PINK1 | 3.23209040 |
| 3 | VRK2 | 3.13067812 |
| 4 | INSRR | 2.82717955 |
| 5 | BUB1 | 2.71130224 |
| 6 | MAP4K2 | 2.59425871 |
| 7 | MYLK | 2.39887068 |
| 8 | OBSCN | 2.32670548 |
| 9 | SRPK1 | 2.25105347 |
| 10 | PDK4 | 2.24269096 |
| 11 | PDK3 | 2.24269096 |
| 12 | MAP2K4 | 2.20054508 |
| 13 | OXSR1 | 2.16386062 |
| 14 | NEK1 | 2.06880798 |
| 15 | BMPR1B | 2.04233192 |
| 16 | FLT3 | 2.03834821 |
| 17 | STK16 | 1.99906589 |
| 18 | CASK | 1.95373256 |
| 19 | TAOK2 | 1.84922190 |
| 20 | MAP2K7 | 1.83437462 |
| 21 | EPHA4 | 1.71019503 |
| 22 | PIM2 | 1.70742492 |
| 23 | NUAK1 | 1.69596649 |
| 24 | SIK1 | 1.68671878 |
| 25 | VRK1 | 1.67785611 |
| 26 | CDC7 | 1.65231910 |
| 27 | NME2 | 1.61563515 |
| 28 | PLK4 | 1.58311861 |
| 29 | PRPF4B | 1.58158106 |
| 30 | TIE1 | 1.52670408 |
| 31 | TRIM28 | 1.49488996 |
| 32 | MAPK12 | 1.47997935 |
| 33 | ADRBK2 | 1.45711568 |
| 34 | PDK2 | 1.43697684 |
| 35 | PLK3 | 1.43533877 |
| 36 | MAP2K3 | 1.42389290 |
| 37 | ZAK | 1.41072515 |
| 38 | WNK4 | 1.39930836 |
| 39 | WNK3 | 1.38892375 |
| 40 | TTK | 1.36601629 |
| 41 | CCNB1 | 1.36376774 |
| 42 | LIMK1 | 1.34373213 |
| 43 | EIF2AK3 | 1.33319361 |
| 44 | STK38L | 1.28441529 |
| 45 | DAPK1 | 1.26330464 |
| 46 | TLK1 | 1.26203794 |
| 47 | CSNK1G2 | 1.24398277 |
| 48 | PLK1 | 1.23236363 |
| 49 | GRK7 | 1.23219585 |
| 50 | PBK | 1.22985467 |
| 51 | MAP3K4 | 1.18188313 |
| 52 | BRSK1 | 1.17152376 |
| 53 | MAPK11 | 1.16528828 |
| 54 | PRKAA2 | 1.13771571 |
| 55 | PAK6 | 1.13606267 |
| 56 | ERBB4 | 1.13237745 |
| 57 | CAMK2G | 1.12917879 |
| 58 | MAPK7 | 1.09806096 |
| 59 | FGFR4 | 1.07551985 |
| 60 | TYK2 | 1.07351980 |
| 61 | PIK3CA | 1.06106467 |
| 62 | BRAF | 1.02863567 |
| 63 | AKT3 | 1.01279260 |
| 64 | MARK1 | 0.98780200 |
| 65 | PLK2 | 0.96815969 |
| 66 | MAP3K6 | 0.96516345 |
| 67 | CDK19 | 0.96453087 |
| 68 | MKNK2 | 0.96311247 |
| 69 | TSSK6 | 0.95564672 |
| 70 | ATR | 0.95297776 |
| 71 | DYRK2 | 0.94980501 |
| 72 | PHKG1 | 0.93041226 |
| 73 | PHKG2 | 0.93041226 |
| 74 | TNIK | 0.92535641 |
| 75 | PRKCG | 0.89922832 |
| 76 | MAP2K6 | 0.89047408 |
| 77 | GRK1 | 0.88998202 |
| 78 | SIK3 | 0.87615366 |
| 79 | PAK3 | 0.87116243 |
| 80 | MINK1 | 0.85545498 |
| 81 | NME1 | 0.84430704 |
| 82 | PKN1 | 0.84419779 |
| 83 | PIK3CG | 0.83963548 |
| 84 | DAPK2 | 0.82199909 |
| 85 | MAP3K12 | 0.81822415 |
| 86 | IRAK3 | 0.80776599 |
| 87 | GRK6 | 0.79414610 |
| 88 | ERBB3 | 0.77744937 |
| 89 | AURKB | 0.76918750 |
| 90 | BCR | 0.76134784 |
| 91 | AURKA | 0.74998234 |
| 92 | ABL2 | 0.74843108 |
| 93 | SGK223 | 0.74604999 |
| 94 | SGK494 | 0.74604999 |
| 95 | SGK2 | 0.72206253 |
| 96 | STK39 | 0.71603771 |
| 97 | MKNK1 | 0.71566438 |
| 98 | CAMK2A | 0.71389500 |
| 99 | BMPR2 | 0.70917474 |
| 100 | MAPK4 | 0.69626538 |
| 101 | CAMK2D | 0.68869887 |
| 102 | MUSK | 0.68862836 |
| 103 | CHEK2 | 0.66514114 |
| 104 | PRKACG | 0.60803928 |
| 105 | EIF2AK1 | 0.60535512 |
| 106 | MAP3K5 | 0.60173066 |
| 107 | MST4 | 0.58688670 |
| 108 | MAP3K3 | 0.56955768 |
| 109 | CSNK2A1 | 0.56797146 |
| 110 | CSNK1G3 | 0.56324886 |
| 111 | WEE1 | 0.56119586 |
| 112 | PRKAA1 | 0.55990437 |
| 113 | TAOK3 | 0.55688063 |
| 114 | BLK | 0.54744943 |
| 115 | MAP3K14 | 0.54527689 |
| 116 | CDK14 | 0.53777904 |
| 117 | MAPKAPK5 | 0.53544007 |
| 118 | DAPK3 | 0.53318580 |
| 119 | ALK | 0.53245700 |
| 120 | CSNK2A2 | 0.52324561 |
| 121 | CAMK4 | 0.52320467 |
| 122 | BRSK2 | 0.52274923 |
| 123 | IRAK2 | 0.51598613 |
| 124 | MAP3K7 | 0.50752707 |
| 125 | PRKACA | 0.50637015 |
| 126 | PKN2 | 0.48708931 |
| 127 | GRK5 | 0.48333683 |
| 128 | CAMK2B | 0.47959278 |
| 129 | CSNK1G1 | 0.47534664 |
| 130 | EIF2AK2 | 0.47422121 |
| 131 | CDK11A | 0.47123824 |
| 132 | CSNK1A1 | 0.46440398 |
| 133 | ATM | 0.46253158 |
| 134 | CSNK1E | 0.46225687 |
| 135 | TESK1 | 0.45703642 |
| 136 | CDK3 | 0.45611967 |
| 137 | IRAK1 | 0.45115746 |
| 138 | RAF1 | 0.44209803 |
| 139 | CDK18 | 0.43865266 |
| 140 | PRKCE | 0.43275497 |
| 141 | CAMK1 | 0.42949265 |
| 142 | CDK15 | 0.42655763 |
| 143 | RPS6KA5 | 0.42318049 |
| 144 | AKT2 | 0.41381202 |
| 145 | MST1R | 0.40679365 |
| 146 | MAP3K11 | 0.40297503 |
| 147 | CHEK1 | 0.40012358 |
| 148 | PRKACB | 0.39199290 |
| 149 | CSNK1A1L | 0.38755079 |
| 150 | PRKCA | 0.38082962 |
| 151 | MAPKAPK3 | 0.37196458 |
| 152 | PRKCQ | 0.36771489 |
| 153 | ARAF | 0.36698652 |
| 154 | JAK2 | 0.36497650 |
| 155 | TTN | 0.36048981 |
| 156 | CDK7 | 0.35021093 |
| 157 | PRKDC | 0.34801966 |
| 158 | ERN1 | 0.33548457 |
| 159 | PRKCZ | 0.32051916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.40981820 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93463159 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.91971109 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.84989010 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.84205389 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81158211 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.74011053 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.58362615 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58169780 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.54180639 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49792235 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46348869 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45687120 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 2.30288205 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26499495 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25597172 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.20610585 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 2.16396868 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 2.13711502 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12147194 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.11143514 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.97722405 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.93839416 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.91617571 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91481408 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.90683224 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.90041732 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.89049908 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87214352 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85567102 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.84221874 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72707109 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72047211 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.70371761 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67577710 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66840948 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64003193 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.63212686 |
| 39 | Homologous recombination_Homo sapiens_hsa03440 | 1.58687808 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58301563 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54249478 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53583088 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52397379 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50754541 |
| 45 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47963698 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44085126 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.40258027 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35626651 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33969867 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32962923 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32636382 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32350259 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29853005 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 1.27161237 |
| 55 | RNA transport_Homo sapiens_hsa03013 | 1.23775521 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23742375 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23680546 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22716600 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22522533 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21328171 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17074146 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15040057 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14323784 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10630581 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.07757582 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06965442 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 1.03840150 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00960509 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94126101 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.92401518 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92122535 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.92086641 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90566696 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86056049 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85959906 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83990327 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81112592 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80139056 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76440685 |
| 80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.75841142 |
| 81 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.75408708 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72744178 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70541889 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68953189 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67045010 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63398213 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62639898 |
| 88 | Cell cycle_Homo sapiens_hsa04110 | 0.60152353 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60028385 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.58633834 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55846713 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50330821 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48516708 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48240573 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47430918 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41523419 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36367830 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34407685 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33778955 |
| 100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.32787035 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30927564 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29372570 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25528839 |
| 104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25356172 |
| 105 | Morphine addiction_Homo sapiens_hsa05032 | 0.23853201 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18591361 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17928319 |
| 108 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17504335 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.16974957 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14943823 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13321861 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12011527 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11794340 |
| 114 | Proteasome_Homo sapiens_hsa03050 | 0.07645679 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04682818 |
| 116 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.03371366 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1703011 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1634997 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1551488 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1391009 |
| 121 | Phototransduction_Homo sapiens_hsa04744 | -0.1266604 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0674724 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | -0.0645482 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | -0.0574453 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | -0.0490218 |
| 126 | * Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0325585 |
| 127 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0303390 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0245428 |
| 129 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0111487 |

